Evidence map›Paper›PMID 42441607›Full record

ArticleExperimental and clinical psychopharmacology2026

Assessing the abuse liability of U.S. Food and Drug Administration-authorized electronic nicotine delivery systems: Impact of nicotine flux, flavor, and menthol cigarette smoking status.

Elizabeth O Ogunleye, Rose S Bono, Rabia Imran, Nicoleta Gaitan, Thokozeni Lipato, Andrew J Barnes, Caroline O Cobb

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and clinical psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elizabeth O OgunleyeDepartment of Psychology, Virginia Commonwealth University.ORCID 0009-0000-6034-5711
Rose S BonoDepartment of Health Policy, School of Public Health, Virginia Commonwealth University.
Rabia ImranDepartment of Psychology, Virginia Commonwealth University.
Nicoleta GaitanDepartment of Psychology, Virginia Commonwealth University.
Thokozeni LipatoDepartment of Internal Medicine, School of Medicine, Virginia Commonwealth University.
Andrew J BarnesDepartment of Health Policy, School of Public Health, Virginia Commonwealth University.
Caroline O CobbDepartment of Psychology, Virginia Commonwealth University.ORCID 0000-0003-3258-252X

Funding

Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3U54DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI BRELAND, ALISON, EISSENBERG, THOMAS EVAN · 2018 to 2022
$20.8M
Wright Regional Center for Clinical and Translational ScienceUM1TR004360 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI FREDERICK Gerard MOELLER · 2023 to 2026
$16.3M
Food and Drug Administration; Center for Tobacco ProductsNational Institutes of Health; National Institute on Drug AbuseNCATS NIH HHS UM1 TR004360NIDA NIH HHS U54 DA036105
6 · The paper itself

Abstract

The U.S. Food and Drug Administration has authorized 41 electronic nicotine delivery systems (ENDS) that meet its public health standard. This clinical lab study utilized behavioral economic and subjective measures to index the abuse liability of currently authorized ENDS that varied in nicotine flux (i.e., μg nicotine/s) and flavor among adults who smoke cigarettes. Using a Latin square-ordered, within-subject design, adults who smoke cigarettes (

Indexed as

Cigarette SmokingElectronic Nicotine Delivery SystemsFlavoring AgentsMentholNicotineAdultFemaleHumansMaleMiddle AgedUnited StatesUnited States Food and Drug AdministrationYoung AdultFlavoring AgentsMentholNicotine

Identifiers

PMID42441607
PMCPMC13367412

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.